company background image
SANI

Sanimed Société AnonymeBVMT:SANIMED Stock Report

Market Cap

د.ت27.3m

7D

0%

1Y

35.8%

Updated

25 Oct, 2021

Data

Company Financials
SANIMED fundamental analysis
Snowflake Score
Valuation1/6
Future Growth0/6
Past Performance0/6
Financial Health1/6
Dividends0/6

SANIMED Overview

Sanimed Société Anonyme, an industrial company, manufactures and sells ceramic sanitary ware for kitchens and bathrooms.

Price History & Performance

Summary of all time highs, changes and price drops for Sanimed Société Anonyme
Historical stock prices
Current Share Priceد.ت2.20
52 Week Highد.ت1.59
52 Week Lowد.ت2.20
Beta-0.34
1 Month Change0%
3 Month Changen/a
1 Year Change35.80%
3 Year Changen/a
5 Year Changen/a
Change since IPO-51.97%

Recent News & Updates

Shareholder Returns

SANIMEDTN BuildingTN Market
7D0%-7.7%-1.8%
1Y35.8%21.3%-1.1%

Return vs Industry: SANIMED exceeded the TN Building industry which returned 26.5% over the past year.

Return vs Market: SANIMED exceeded the TN Market which returned -1.2% over the past year.

Price Volatility

Is SANIMED's price volatile compared to industry and market?
SANIMED volatility
SANIMED Beta-0.34
Industry Beta0.51
Market Beta1

Stable Share Price: Insufficient data to determine SANIMED's volatility over the past 3 months.

Volatility Over Time: Insufficient data to determine SANIMED's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
1998n/an/ahttps://www.sanimed.com.tn

Sanimed Société Anonyme, an industrial company, manufactures and sells ceramic sanitary ware for kitchens and bathrooms. It offers bathroom components, including washbasins, such as built-in washbasins, and column mounted or suspended washbasins; toilet bowls; bidets; shower trays; decorated bowls; kitchen sinks; and various other products. The company was founded in 1998 and is headquartered in Sfax, Tunisia.

Sanimed Société Anonyme Fundamentals Summary

How do Sanimed Société Anonyme's earnings and revenue compare to its market cap?
SANIMED fundamental statistics
Market Capد.ت27.28m
Earnings (TTM)-د.ت3.67m
Revenue (TTM)د.ت53.23m

0.5x

P/S Ratio

-7.4x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
SANIMED income statement (TTM)
Revenueد.ت53.23m
Cost of Revenueد.ت29.30m
Gross Profitد.ت23.94m
Expensesد.ت27.61m
Earnings-د.ت3.67m

Last Reported Earnings

Jun 30, 2021

Next Earnings Date

n/a

Earnings per share (EPS)-0.30
Gross Margin44.97%
Net Profit Margin-6.89%
Debt/Equity Ratio386.3%

How did SANIMED perform over the long term?

See historical performance and comparison

Valuation

Is Sanimed Société Anonyme undervalued compared to its fair value and its price relative to the market?

1.15x

Price to Book (PB) ratio


Share Price vs. Fair Value

Below Fair Value: Insufficient data to calculate SANIMED's fair value to establish if it is undervalued.

Significantly Below Fair Value: Insufficient data to calculate SANIMED's fair value to establish if it is undervalued.


Price To Earnings Ratio

PE vs Industry: SANIMED is unprofitable, so we can't compare its PE Ratio to the African Building industry average.

PE vs Market: SANIMED is unprofitable, so we can't compare its PE Ratio to the TN market.


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate SANIMED's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: SANIMED is good value based on its PB Ratio (1.2x) compared to the XF Building industry average (1.6x).


Future Growth

How is Sanimed Société Anonyme forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

11.4%

Forecasted Capital Goods industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Sanimed Société Anonyme has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Past Performance

How has Sanimed Société Anonyme performed over the past 5 years?

-63.8%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: SANIMED is currently unprofitable.

Growing Profit Margin: SANIMED is currently unprofitable.


Past Earnings Growth Analysis

Earnings Trend: SANIMED is unprofitable, and losses have increased over the past 5 years at a rate of 63.8% per year.

Accelerating Growth: Unable to compare SANIMED's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: SANIMED is unprofitable, making it difficult to compare its past year earnings growth to the Building industry (6.6%).


Return on Equity

High ROE: SANIMED has a negative Return on Equity (-15.49%), as it is currently unprofitable.


Financial Health

How is Sanimed Société Anonyme's financial position?


Financial Position Analysis

Short Term Liabilities: SANIMED's short term assets (TND64.3M) exceed its short term liabilities (TND62.9M).

Long Term Liabilities: SANIMED's short term assets (TND64.3M) do not cover its long term liabilities (TND69.4M).


Debt to Equity History and Analysis

Debt Level: SANIMED's debt to equity ratio (386.3%) is considered high.

Reducing Debt: SANIMED's debt to equity ratio has increased from 226.6% to 386.3% over the past 5 years.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: SANIMED has less than a year of cash runway based on its current free cash flow.

Forecast Cash Runway: SANIMED has less than a year of cash runway if free cash flow continues to reduce at historical rates of 4.1% each year


Dividend

What is Sanimed Société Anonyme current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

Notable Dividend: Unable to evaluate SANIMED's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate SANIMED's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if SANIMED's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if SANIMED's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of SANIMED's dividend in 3 years as they are not forecast to pay a notable one for the TN market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?


CEO

Sanimed Société Anonyme has no CEO, or we have no data on them.


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Sanimed Société Anonyme's employee growth, exchange listings and data sources


Key Information

  • Name: Sanimed Société Anonyme
  • Ticker: SANIMED
  • Exchange: BVMT
  • Founded: 1998
  • Industry: Building Products
  • Sector: Capital Goods
  • Market Cap: د.ت27.280m
  • Shares outstanding: 12.40m
  • Website: https://www.sanimed.com.tn

Number of Employees


Location

  • Sanimed Société Anonyme
  • Route de gremda km 10.5
  • Sfax
  • Tunisia

Listings


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2021/10/25 15:01
End of Day Share Price2021/09/07 00:00
Earnings2021/06/30
Annual Earnings2020/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.